Importantly, Kaplan–Meier survival curves and log-rank tests revealed that patients with combined high HOMER3 expression and positive nuclear β-Catenin expression suffered poorest 5-year DMFS and OS in breast cancer patients (Fig. 7c). The gene discussed is HOMER3; the disease is breast carcinoma.